Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia.
Bignon A, Régent A, Klipfel L, Desnoyer A, de la Grange P, Martinez V, Lortholary O, Dalloul A, Mouthon L, Balabanian K. Bignon A, et al. Among authors: desnoyer a. Blood. 2015 Apr 16;125(16):2507-18. doi: 10.1182/blood-2014-08-598565. Epub 2015 Mar 2. Blood. 2015. PMID: 25733583 Free article.
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher V; ANRS 154 LENAKAP trial group. Desnoyer A, et al. Br J Dermatol. 2016 Dec;175(6):1251-1262. doi: 10.1111/bjd.14748. Epub 2016 Oct 12. Br J Dermatol. 2016. PMID: 27177037 Clinical Trial.
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.
Cuffel A, Allain V, Faivre L, Di Blasi R, Morin F, Vercellino L, Chevalier MF, Desnoyer A, de Jorna R, Madelaine I, Parquet N, Brignier AC, Thieblemont C, Larghero J, Caillat-Zucman S, Mebarki M. Cuffel A, et al. Among authors: desnoyer a. Blood Adv. 2022 Aug 9;6(15):4657-4660. doi: 10.1182/bloodadvances.2022007057. Blood Adv. 2022. PMID: 35728051 Free PMC article. No abstract available.
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D. Pourcher V, et al. Among authors: desnoyer a. AIDS Res Hum Retroviruses. 2017 Jan;33(1):1-10. doi: 10.1089/AID.2016.0069. Epub 2016 Sep 7. AIDS Res Hum Retroviruses. 2017. PMID: 27405442 Clinical Trial.
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers.
Duchemann B, Naigeon M, Auclin E, Ferrara R, Cassard L, Jouniaux JM, Boselli L, Grivel J, Desnoyer A, Danlos FX, Mezquita L, Caramella C, Marabelle A, Besse B, Chaput N. Duchemann B, et al. Among authors: desnoyer a. J Immunother Cancer. 2022 Feb;10(2):e004012. doi: 10.1136/jitc-2021-004012. J Immunother Cancer. 2022. PMID: 35131864 Free PMC article.
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G. Desnoyer A, et al. J Hepatol. 2016 Jul;65(1):40-47. doi: 10.1016/j.jhep.2016.02.044. Epub 2016 Mar 4. J Hepatol. 2016. PMID: 26952005
36 results